Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Apr 01, 2005 (Vol. 25, No. 7)

BiologyBrowser.org

URL:www.biologybrowser.org/
  • Excellent Organization of links, news
  • None
With a name like BiologyBrowser, this site has a leg up on many others. It sounds interesting, and unlike many others, it is interesting. The organizers deserve a lot of credit. Aimed at a very broad audience, BiologyBrowser is like the Wall Street darling that exceeds expectations. With a tightly organized opening page, the site provides visitors easy access to up-to-the-minute News, a superbly organized collection of biological information organized by Organism, Subject, and Geography, and a search engine that allows easy alternative access to the same information. In a few clicks, visitors can travel to sites all over the Web covering many species of interest. Yes, this is a link-based site, but it is so well done that you’ll look at it differently from almost any other link site you’ve seen before.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »